ѻý

New E. Coli Outbreak; How ECMO Redefines Death; A Step Closer to Universal Blood

<ѻý class="mpt-content-deck">— Health news and commentary gathered by ѻý staff
MedpageToday
Morning Break over illustration of a syringe, Covid virus, and DNA helix over a photo of green vegetation.

Note that some links may require registration or subscription.

The CDC warned of an Escherichia coli (E. coli) outbreak tied to in food co-ops or natural food stores such as Whole Foods and Market of Choice.

A genome-wide analysis identified linked with blood pressure. (Nature Genetics)

The New Yorker looked at how extracorporeal membrane oxygenation (ECMO) is .

Zhang Yongzhen, PhD, the Chinese scientist who first published COVID's virus sequence, after a days-long protest. (AP)

Competition from "skinny-label" generics from 2015 to 2021. (Annals of Internal Medicine)

The first trial over claims that (Zantac) causes cancer is set to begin this week in Chicago. (Reuters)

Meanwhile, Johnson & Johnson said it will pay claiming the company's talcum powder caused ovarian cancer. (CNBC)

The World Health Organization issued a report that changes how airborne transmission of ; will the CDC follow suit? (KFF Health News)

Prince William said his is "doing well" in a rare health update. (In Style)

Mental health diagnoses rose in all age groups and in all states since 2019, a FAIR Health showed.

The Leapfrog Group released its spring , finding improvements in patient experience reports and healthcare-associated infections.

Loneliness followed a throughout life: it was higher in younger and older adulthood, and lowest during middle adulthood, according to an analysis of nine studies. (Psychological Sciences)

A series of high-profile killings focused public attention on whether is adequate in the U.K. (The Guardian)

Mucin-degrading gut bacteria may be sources of enzymes to for transfusions. (Nature Microbiology)

The advocacy group Public Citizen asked the CDC and FDA to revise a recent advisory about counterfeit to include the possibility of iatrogenic botulism from approved botulinum toxin drugs.

FDA of valbenazine (Ingrezza Sprinkle) for tardive dyskinesia and chorea associated with Huntington's disease in adults with difficulty swallowing, drugmaker Neurocrine Biosciences announced.

The FDA will hold a to learn how it can improve its advisory committee meetings.